The NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN) is a collaborative network of local health district, health network and non-government organisation alcohol and other drug (AOD) services committed to working together to enhance clinical research throughout NSW AOD services.

Supported by the Ministry of Health, DACRIN is a member led organisation which aims to improve clinical research across the NSW AOD sector by providing opportunities for:

  • collaborations and partnerships between AOD services, clinicians, researchers and consumers
  • sharing of resources
  • improving the experiences of people impacted by alcohol and other drugs
  • facilitating high quality research with outcomes that matter.

Find out more about us.

DACRIN membership


DACRIN membership is open to organisations within the state of NSW who provide AOD services to clients.

We support our member organisations by providing opportunities for.

  • participation in research
  • partnerships and collaborations
  • enhanced funding opportunities
  • greater efficiencies through resource sharing
  • free or discounted training opportunities with industry partners  
  • voting rights at DACRIN Council meetings,

Become a member organisation and contribute to enhancing clinical research throughout NSW AOD services and improving experiences of people impacted by alcohol and other drugs.

Find out more about our membership including how to apply.

Organisation Affiliates

Any person that works for a DACRIN member organisation may register as a member affiliate.

Member affiliates will be provided with access to the DACRIN SharePoint site, a members only platform containing shared resources including no cost or discounted SophieMephamGCPTM Good Clinical Practice (GCP) courses, and an online library of standardised, downloadable REDCap electronic Case Report Forms specific to AOD research.

Find out how to register as a member affiliate.

DACRIN research

DACRIN conducts and supports investigator led clinical research that focuses on improving safety, efficiency, clinical outcomes and client experiences of AOD services.

DACRIN member organisations have supported over 30 research projects to date including cutting edge national and international clinical trials targeting a range of AOD therapeutic areas including opioid use disorder, methamphetamine dependence and treatment resistant cannabis dependence.

Find out more about our research.

Current as at: Tuesday 31 January 2023